Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rivaroxaban (xarelto) (1 trial)
Thrombosis (Phase 3)
Venous Thrombosis (Phase 3)
Trials (1 total)
Trial APIs (1 total)